Industry | Biotechnology |
---|---|
Founded | 1996 |
Headquarters | Brussels, Belgium |
Key people | Stephan Tanda, Chairman Nathalie Moll, Secretary General |
Website | http://www.europabio.org |
EuropaBio (The European Association for Bioindustries) is Europe's largest and most influential biotech industry group, whose members include Monsanto, Bayer and other biotechnology companies.[1] The organisation was initiated in 1996 to represent the interests of the biotechnology industry at European level and therefore influence legislation that serves the interests of biotechnology companies in Europe.
Contents |
EuropaBio is engaged in dialogue with the European institutions and contribute to the creation of legislation for bioindustries. It ensures a steady flow of information about biotechnology to the European Parliament, the European Commission and the Council of Ministers.
EuropaBio represents the three traditional sectors of the biotech industry.
EuropaBio:
EuropaBio's primary focus is the European Union but because of the global character of the biotech business, it also represents its members in transatlantic and worldwide fora.
The association policy goals are:
EuropaBio believes there is "an urgent need to reshape the terms of the debate about GM in Europe."[3] In an effort to transform European policy relating to the production and distribution of genetically modified foods within the EU, EuropaBio has proposed the creation of an "outreach program."[4] This entails recruiting high profile "ambassadors" in an effort to sway opinion on GM policy by lobbying European leaders directly. A public relations company working for EuropaBio claimed that a number of well known public figures had expressed interest in the ambassadorial positions. They include Sir Bob Geldof; the chancellor of Oxford University and BBC Trust chairman, Lord Patten; former Irish EU commissioner and attorney general David Byrne, and "potentially" the involvement of former UN secretary general Kofi Annan. The pro-GM science writer Mark Lynas was also approached. The PR firm will research, write, and then place articles but with attribution assigned to the various ambassadors. The firm will also arrange interviews and speaking engagements with international media, as well as speaking slots at major conferences. EuropaBio intends to introduce the ambassadors to high-level European bureaucrats and MEPs in with the goal of making a stronger case for GM within EU institutions.[5][6][7]
EuropaBio has a board of management made up of representatives from among its industry members. In June 2011, Dr. Stephan Tanda, Royal DSM Board Member, was appointed for two years as Chair of the Board, prior to that the appointment was held by Dr. Andrea Rappagliosi (GlaxoSmithKline).[8]
The Board is assisted by sectoral councils representing the main segments of EuropaBio - healthcare (red biotech), industrial (white biotech) and agriculture (green biotech).
Experts from member companies and national associations participate in EuropaBio's working groups which cover a very wide range of issues and areas of concern of biotech enterprises.
EuropaBio Secretary General is Mrs Nathalie Moll.[9]
In September 2010, the association represents 66 corporate members operating worldwide, 7 associate members, 4 BioRegions and 22 national biotechnology associations.[10] Through the national associations, EuropaBio represents 1800 small and medium-sized enterprises.